Insider trades
Philippe Menu, Chief Officer of SOPHiA Genetics SOPH, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $227.1K. The latest trade was on 06/25.
Philippe Menu
Chief Medical Officer
- Company
- SOPHiA Genetics SOPH
- First filing
- 25/01/27
- Trades
- 20 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- −$227.1K
- Last trade
- 06/25
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/25 | 06/26 | 5,000 sh | $5.50 | $27,500 | −2.0% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/12 | 06/15 | 5,000 sh | $4.95 | $24,750 | −2.0% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/26 | 06/01 | 5,000 sh | $4.95 | $24,750 | −2.0% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/19 | 05/20 | 608 sh | $4.61 | $2,802.88 | −0.2% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/12 | 05/13 | 5,000 sh | $4.67 | $23,350 | −1.9% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 04/27 | 04/28 | 5,000 sh | $4.82 | $24,100 | −1.9% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 04/20 | 04/21 | 608 sh | $5.20 | $3,161.6 | −0.2% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 04/14 | 04/16 | 1,600 sh | $4.96 | $7,936 | −0.6% |
| Open-market sale10b5-1 plan | 04/10–04/13 | 04/14 | 8,125 sh3 trades | $4.72avg. | $38,377 | −2.9% | |
| Open-market sale10b5-1 plan | 04/08–04/09 | 04/10 | 4,731 sh2 trades | $4.80avg. | $22,704.94 | −1.7% | |
| Open-market sale10b5-1 plan | 04/06–04/07 | 04/08 | 5,100 sh2 trades | $4.86avg. | $24,783 | −1.8% | |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 03/19 | 03/20 | 608 sh | $4.79 | $2,912.32 | −0.3% |